Chromosome 20 trisomy
disease diseaseOn this page
Also known as mosaic trisomy 20trisomy 20trisomy 20 mosaicismtrisomy chromosome 20
Summary
Chromosome 20 trisomy (MONDO:0022757) is a disease. A subtype of chromosome 20 disorder — broader associated-gene and molecular evidence is on the parent page (see Disease family below).
Clinical features
No curated clinical features (Orphanet) for this disease.
Identifiers
Disease identifiers
| Field | Value |
|---|---|
| Canonical name | chromosome 20 trisomy |
| Mondo ID | MONDO:0022757 |
| MeSH | C535372 |
| NCIT | C36397 |
| UMLS | C5979883 |
| MedGen | 1876538 |
| GARD | 0005332 |
| Is cancer (heuristic) | no |
Also known as: mosaic trisomy 20 · trisomy 20 · trisomy 20 mosaicism · trisomy chromosome 20
Data availability: 4 cell lines.
Disease family
An umbrella term covering 1 Mondo subtype.
Classification path: disease › human disease › disease by etiologic mechanism › disease of genetic or genomic mechanism › chromosomal disorder › autosomal anomaly › chromosome 20 disorder › chromosome 20 trisomy
Related subtypes (5): ring chromosome 20, partial deletion of chromosome 20, partial trisomy of chromosome 20, maternal uniparental disomy of chromosome 20, paternal uniparental disomy of chromosome 20
Subtypes (1): mosaic trisomy 20
Genetics & variants
GWAS landscape
No GWAS associations recorded — common-variant (GWAS) studies don’t cover this disease (typical for Mendelian / rare diseases). See the curated gene cohort and Mendelian overlap below.
Variant details and genetic-evidence tiers
No tiered GWAS variants or ClinVar records for this disease.
Genes & proteins
No associated-gene cohort resolved for this disease. Atlas builds the molecular and therapeutic sections — associated genes, protein families, druggability, pathways, interactions, and drug associations — by aggregating over a disease’s associated genes (resolved via GWAS / GenCC / ClinVar / CIViC), and none resolved here. This is expected for antibody-mediated, autoimmune, or otherwise non-gene-defined conditions; the curated evidence for this disease is its clinical features, GWAS susceptibility, and clinical trials (above).
Function
No pathway enrichment — requires an associated-gene cohort.
Therapeutics
No druggable-target or therapeutic data for this disease’s cohort.
Clinical trials & evidence
Clinical trials
Clinical trials: 0.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.